Amneal Pharmaceuticals, Inc. AMRX Ireland — Long-Lived Assets
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NoncurrentAssets.
The official record: Amneal Pharmaceuticals, Inc.’s 10-K, filed February 27, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amneal Pharmaceuticals, Inc.'s ireland — long-lived assets.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amneal Pharmaceuticals, Inc.'s ireland — long-lived assets?
- Amneal Pharmaceuticals, Inc. (AMRX) reported ireland — long-lived assets of $60.15M in Q4 2025.
- How has Amneal Pharmaceuticals, Inc.'s ireland — long-lived assets changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s ireland — long-lived assets increased by 12.8% year-over-year, from $53.34M to $60.15M.
- What does ireland — long-lived assets mean?
- This metric represents the total book value of non-current, tangible, and intangible assets physically located or legally domiciled within the Ireland geographic segment. It reflects the company's investment in regional manufacturing infrastructure, research facilities, and intellectual property holdings essential for international operations. Monitoring this balance helps investors assess the geographic concentration of capital expenditure and the scale of operational footprint in this specific jurisdiction.